MetLife Investment Management, LLC - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 196 filers reported holding NEVRO CORP in Q2 2018. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2023$364,027
-24.4%
18,9400.0%0.00%
-25.0%
Q2 2023$481,455
-29.7%
18,9400.0%0.00%
-20.0%
Q1 2023$684,681
-8.7%
18,9400.0%0.01%
-16.7%
Q4 2022$750,024
-15.0%
18,9400.0%0.01%
-25.0%
Q3 2022$882,604
+6.3%
18,9400.0%0.01%
+14.3%
Q2 2022$830,140
-39.4%
18,9400.0%0.01%
-22.2%
Q1 2022$1,369,930
+39.6%
18,940
+56.5%
0.01%
+12.5%
Q4 2021$981,109
-30.3%
12,1020.0%0.01%
-38.5%
Q3 2021$1,408,431
-29.8%
12,1020.0%0.01%
-31.6%
Q2 2021$2,006,391
+12.6%
12,102
-5.2%
0.02%
+11.8%
Q1 2021$1,781,415
-23.5%
12,770
-5.1%
0.02%
-29.2%
Q4 2020$2,329,753
+18.9%
13,459
-4.3%
0.02%
+14.3%
Q3 2020$1,959,533
+10.9%
14,067
-4.9%
0.02%
+5.0%
Q2 2020$1,766,722
+35.6%
14,788
+13.5%
0.02%
+11.1%
Q1 2020$1,302,739
-14.9%
13,0300.0%0.02%
+12.5%
Q4 2019$1,531,546
+36.7%
13,0300.0%0.02%
+23.1%
Q3 2019$1,120,189
+32.6%
13,0300.0%0.01%
+44.4%
Q2 2019$844,735
+3.7%
13,0300.0%0.01%0.0%
Q1 2019$814,505
+60.7%
13,0300.0%0.01%
+50.0%
Q4 2018$506,737
-31.8%
13,0300.0%0.01%
-25.0%
Q3 2018$742,710
-28.6%
13,0300.0%0.01%
-33.3%
Q2 2018$1,040,000
-7.9%
13,0300.0%0.01%
-7.7%
Q1 2018$1,129,000
+25.4%
13,0300.0%0.01%
+30.0%
Q4 2017$900,00013,0300.01%
Other shareholders
NEVRO CORP shareholders Q2 2018
NameSharesValueWeighting ↓
BRAIDWELL LP 1,632,915$59,029,8771.95%
Rock Springs Capital Management LP 1,077,900$38,966,0850.93%
Numerai GP LLC 50,716$1,833,3830.61%
ArrowMark Colorado Holdings LLC 1,331,756$48,142,9790.55%
K2 PRINCIPAL FUND, L.P. 101,600$3,672,8400.50%
Kula Investments, LLC 33,810$1,222,2320.30%
FRED ALGER MANAGEMENT, LLC 1,174,243$42,448,8850.23%
Woodline Partners LP 368,606$13,325,1070.18%
Quantamental Technologies LLC 7,823$282,8010.15%
FOX RUN MANAGEMENT, L.L.C. 11,467$414,5320.14%
View complete list of NEVRO CORP shareholders